Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

CEC levels may be a useful marker for predicting prostate cancer progression.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Glioblastoma cells can make androgens, which might help the tumor grow.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.